Adult Autoimmune Myopathies (MAIA)
ConditionIdiopathic Inflammatory Myopathies
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Brest
About this trial
This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical suspicion of Adult Inflammatory Myopathy
Social security affiliation
Disqualifiers
Pregnant and lactating women
Patients unable to consent
Patients refusing to participate in the research.
Patients under legal protection
Trial design
Design model
Single group
Treatments tested in this trial
description of adult autoimmune myopathies
Other interventiondescription of adult autoimmune myopathies
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: Adult Autoimmune MyopathiesOther 1 intervention
Trial outcomes
Primary outcomes
1
Distribution of lymphocytes subpopulations (B, T and TH-17)
Distribution of lymphocytes subpopulations (B, T and TH-17) according to the final diagnosis defined by a panel of experts
Time frame
6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov